Endovascular Today11d
Contego’s Neuroguard IEP System Used in First Commercial Procedures
Contego Medical announced the first commercial procedures were performed with the company’s Neuroguard IEP system. Ac ...
Endovascular Today11d
Biotronik’s BIO-OSCAR FIRST Trial Begins Enrollment
Biotronik announced the enrollment of the first patients in its BIO-OSCAR FIRST trial, which is designed to confirm the ...
Endovascular Today13d
Flow Medical Secures Seed Funding for Pulmonary Embolism Therapy
Flow Medical announced the closing of a $5 million seed funding round that will allow the company to accelerate the ...
Endovascular Today10d
Humacyte’s Symvess ATEV Approved by FDA for Treatment of Extremity Vascular Trauma
Humacyte, Inc. announced that the FDA has granted full approval for the company’s Symvess—acellular tissue enginee ...
Endovascular Today7d
Avicenna.AI’s Cina-iPE and Cina-ASPECTS Tools Integrated Into Viz.ai One Platform
Viz.ai and Avicenna.AI recently announced that Viz.ai is integrating Avicenna.AI’s Cina-iPE and Cina-ASPECTS tools ...
Endovascular Today11d
Case Report: Successful First Case With the Pounce™ Thrombectomy System to Remove Popliteal and Proximal Tibial Thrombi
Patient Presentation A man in his late 50s presented to the emergency department with 4 weeks of acute-onset, severely ...
Endovascular Today10d
Merit Medical’s Wrapsody Receives FDA Approval
December 20, 2024—Merit Medical Systems, Inc. announced that the Wrapsody cell-impermeable endoprosthesis has received premarket approval from the FDA. The company stated that it can begin ...